Iron metabolism and lymphocyte characterisation during Covid-19 infection in ICU patients: an observational cohort study

Table 1 Demographic and general sample description

Reported cases	Male (%)	Female (%)
Gender (M/F)	25 (81)	6 (19)
Variables	Male (median (IQR))	Female (median (IQR))
Age (year)	62 (57–67)	71 (62–74)
BMI (kg/m²)	27.8 (25.3–31.1)	29.4 (29.3–30.8)
Symptoms-to-ICU (days)	9 (8–12)	7 (7–7)
In-hospital pre-ICU LOS (days)	2 (1–5)	2.5 (2–3)
ICU LOS	14 (9–19)	12.5 (11.2–16.7)
PFmed	195 (159.5–220)	165.5 (136.1–183.3)
PLR	436 (218–623)	305 (180–565)
CT scan (L:H)	6:15	2:2
Intubated patients (%)	22 of 25 (88)	6 of 6 (100)
Tracheostomy (%)	21 of 25 (84)	4 of 6 (67)
VAPs (%)	13 of 25 (52)	2 of 6 (33)
Pro-coagulative disorders (%)	3 of 25 (12)	0 of 6 (0)
Pnx (%)	7 of 25 (28)	1 of 6 (17)
CRRT (%)	10 of 25 (40)	1 of 6 (17)
Admitted from other centres (%)	12 of 25 (48)	3 of 6 (50)
Mortality (%)	7 of 21 (33) 4 men still admitted in our ICU	1 of 6 (17)

BMI body mass index, CRRT continuous renal-replacement therapy, CT scan computed tomography (only those with both images and radiologic report available—H stays for high-elastance pattern and L stays for low-elastance pattern), ICU intensive care unit, IQR interquartile range, LOS length of stay, Mortality 21 men over 25 enrolled because 4 are still in our ICU, PFmed means PaO₂/FiO₂ ratio during the first 24 h of ICU stay, PLR platelet-to-lymphocyte ratio on the day of ICU admission, Pnx pneumothorax, Pro-coagulative disorders deep-vein thrombosis, ischaemic stroke or massive pulmonary embolism, VAP ventilator-acquired pneumonia

ISSN: 1749-7922